cyproheptadine and lfm a13

cyproheptadine has been researched along with lfm a13 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Goldstein, DM; Kondru, RK; Kuglstatter, A; Lou, Y; Owens, TD	1

Reviews

1 review(s) available for cyproheptadine and lfm a13

Article	Year
Bruton's tyrosine kinase inhibitors: approaches to potent and selective inhibition, preclinical and clinical evaluation for inflammatory diseases and B cell malignancies. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Agammaglobulinaemia Tyrosine Kinase; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Catalytic Domain; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Industry; Humans; Inflammation; Leukemia, B-Cell; Models, Molecular; Protein Conformation; Protein-Tyrosine Kinases; Structure-Activity Relationship	2012

Article

Year

Bruton's tyrosine kinase inhibitors: approaches to potent and selective inhibition, preclinical and clinical evaluation for inflammatory diseases and B cell malignancies.

Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

Topics: Agammaglobulinaemia Tyrosine Kinase; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Catalytic Domain; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Industry; Humans; Inflammation; Leukemia, B-Cell; Models, Molecular; Protein Conformation; Protein-Tyrosine Kinases; Structure-Activity Relationship

2012